Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 1/20 | 0.39 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.39 |
| ▸ | ECE1 | P42892 | 1/20 | 0.38 |
| ▸ | MAOB | P27338 | 3/20 | 0.37 |
| ▸ | MAOA | P21397 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 3/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.35 |
| ▸ | BLM | P54132 | 1/20 | 0.35 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.35 |
| ▸ | PAOX | Q6QHF9 | 2/20 | 0.33 |
| ▸ | ST14 | Q9Y5Y6 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | TERT | O14746 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12081771 | 0.86 | ALDH1A1 (0.43) | ALDH1A1ALOX15CYP2C9HPGDCYP2C19 | |
| SCHEMBL23813807 | 0.80 | ALDH1A1 (0.40) | ALDH1A1ALOX15CYP2C9HPGDCYP2C19 | |
| SCHEMBL2554762 | 0.79 | ECE1 (0.43) | ALDH1A1ALOX15CYP2C9HPGDCYP2C19 | |
| SCHEMBL9570865 | 0.79 | ALDH1A1 (0.42) | ALDH1A1HSD17B10ECE1MEN1KMT2A | |
| SCHEMBL5892041 | 0.78 | TSHR (0.45) | ALDH1A1MAOBMAOATSHRTPSAB1 | |
| SCHEMBL152135 | 0.78 | — | — | |
| SCHEMBL38654455 | 0.78 | ALDH1A1 (0.42) | ALDH1A1ALOX15CYP2C9HPGDCYP2C19 | |
| SCHEMBL24427061 | 0.78 | — | — | |
| SCHEMBL18530336 | 0.77 | FAAH (0.45) | ALDH1A1HPGDECE1TSHRMEN1 | |
| SCHEMBL5152982 | 0.77 | MCL1 (0.50) | ALDH1A1HSD17B10ECE1TSHRMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117800868-A | Low-viscosity self-thixotropic polyaspartic acid ester and preparation method and application thereof | 深圳飞扬骏研新材料股份有限公司 | 2024-04-02 | — | — | CN | claimed |
| US-7413727-B2 | Contrast agents | GE HEALTHCARE AS (NO) | 2008-08-19 | — | — | US | claimed |
| EP-1442751-B1 | Diagnostic imaging technique | GE HEALTHCARE AS (NO) | 2007-06-20 | — | — | EP | claimed |
| EP-1442751-A1 | Method of imaging | Amersham Health AS (NO) | 2004-08-04 | — | — | EP | claimed |
| EP-0977600-B1 | CONTRAST AGENTS TARGETTING RECEPTORS ASSOCIATED WITH ANGIOGENESIS | AMERSHAM HEALTH AS (NO) | 2004-06-30 | — | — | EP | claimed |
| US-20040009122-A1 | Contrast agents | AMERSHAM HEALTH AS (NO) | 2004-01-15 | — | — | US | claimed |
| US-6610269-B1 | Disease state imaged using a targeted contrast agent of the formula V-L-R, where V is a vector moiety having affinity for an angiogenesis-related endothelial cell receptor, L is a linker, R is a macromolecular or particulate label | AMERSHAM HEALTH AS (NO) | 2003-08-26 | — | — | US | claimed |
| EP-0977600-A2 | CONTRAST AGENTS | NYCOMED IMAGING A/S (NO) | 2000-02-09 | — | — | EP | claimed |
| WO-1998047541-B1 | CONTRAST AGENTS | — | 1998-11-26 | — | — | WO | claimed |
| WO-1998047541-A1 | CONTRAST AGENTS | NYCOMED IMAGING AS (NO) | 1998-10-29 | — | — | WO | claimed |
| CN-117800868-A | Low-viscosity self-thixotropic polyaspartic acid ester and preparation method and application thereof | 深圳飞扬骏研新材料股份有限公司 | 2024-04-02 | — | — | CN | disclosed |
| CN-117800868-A | Low-viscosity self-thixotropic polyaspartic acid ester and preparation method and application thereof | 深圳飞扬骏研新材料股份有限公司 | 2024-04-02 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040009122-A1 | Contrast agents | FLT1, FLT4, KDR | ALDH1A1 4212/4885ALOX15 3219/4885CYP2C9 4648/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.